RediNews
ETFs Holding MGNX »    MGNX Historical Stock Prices »
MGNX News Video: Tue, Jun 28, 2016, 2:04 PM — Tuesday's ETF Movers: XBI, RHS


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MacroGenics is a biopharmaceutical company focused on discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer. Co. has a pipeline of product candidates in human clinical testing that have been created primarily using its proprietary technology platforms, which also have applicability across other therapeutic domains, including autoimmune disorders and infectious disease. Co.'s primary clinical product candidate is margetuximab, a monoclonal antibody that targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers. Self directed investors in MacroGenics, Inc will be interested in keeping up with all MacroGenics, Inc news they can find, both MGNX news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on MGNX. At RediNews, we simplify this task by presenting both MGNX news releases originating from MacroGenics, Inc itself, and MGNX news from a variety of media outlets. Visitors can browse this news online and through our MGNX RSS news feed.

MGNX News

MGNX News — Articles, Videos, & Press Releases

MGNX Makes Notable Cross Below Critical Moving Average
Thursday, March 7, 2019, 1:30 PM — Market News Video
MacroGenics Stock Sees Short Interest Drop 41.8%
Thursday, February 28, 2019, 11:40 AM — Market News Video
Investors Snatch MGNX Even Cheaper Than Its Secondary Stock Offering
Wednesday, February 27, 2019, 10:07 AM — Dividend Channel
Frontier Communications' (FTR) Q4 Earnings: What's in Store?
Thursday, February 21, 2019, 6:45 AM — Zacks
What's in Store for Telefonica Brasil (VIV) in Q4 Earnings?
Monday, February 18, 2019, 7:23 AM — Zacks
Notable Wednesday Option Activity: MGNX, CUB, CC
Wednesday, February 6, 2019, 3:17 PM — Stock Options Channel
Analysts Forecast 13% Upside For IUSS
Wednesday, February 6, 2019, 7:49 AM — ETF Channel
Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth?
Thursday, January 31, 2019, 9:58 AM — Zacks
MacroGenics Enters Oversold Territory (MGNX)
Tuesday, January 22, 2019, 12:01 PM — Dividend Channel
What Lies Ahead for Abbott (ABT) Stock This Earnings Season?
Friday, January 18, 2019, 5:36 AM — Zacks
Short Interest Increases 18.6% For MGNX
Friday, January 11, 2019, 12:16 PM — Market News Video
Analysts Expect IUSS To Hit $26
Wednesday, January 2, 2019, 8:11 AM — ETF Channel
February 2019 Options Now Available For MacroGenics (MGNX)
Monday, December 24, 2018, 11:11 AM — Stock Options Channel
MacroGenics Becomes Oversold (MGNX)
Monday, December 10, 2018, 12:11 PM — Dividend Channel
Analysts Anticipate IUSS To Hit $26
Monday, November 26, 2018, 7:45 AM — ETF Channel
First Week of November 16th Options Trading For MacroGenics (MGNX)
Friday, November 9, 2018, 10:59 AM — Stock Options Channel
Sum Up The Parts: IEIH Could Be Worth $32
Wednesday, October 24, 2018, 8:16 AM — ETF Channel
Commit To Buy MacroGenics At $20, Earn 18.5% Annualized Using Options
Monday, October 8, 2018, 12:01 PM — Stock Options Channel
MGNX Makes Notable Cross Below Critical Moving Average
Friday, September 21, 2018, 11:52 AM — Market News Video
Sum Up The Parts: PBE Could Be Worth $66
Monday, August 6, 2018, 8:33 AM — ETF Channel
MacroGenics Breaks Above 200-Day Moving Average - Bullish for MGNX
Thursday, July 5, 2018, 5:10 PM — Market News Video
Look Under The Hood: PBE Has 14% Upside
Tuesday, July 3, 2018, 8:08 AM — ETF Channel
First Week of MGNX August 17th Options Trading
Monday, June 25, 2018, 10:48 AM — Stock Options Channel
Peek Under The Hood: TUSA Has 10% Upside
Wednesday, May 30, 2018, 8:19 AM — ETF Channel
MacroGenics is Now Oversold (MGNX)
Tuesday, May 8, 2018, 11:59 AM — Dividend Channel
Peek Under The Hood: VXF Has 10% Upside
Friday, April 13, 2018, 8:33 AM — ETF Channel
Notable Wednesday Option Activity: SQ, MGNX, ATVI
Wednesday, March 28, 2018, 3:34 PM — Stock Options Channel
First Week of May 18th Options Trading For MacroGenics (MGNX)
Wednesday, March 28, 2018, 10:51 AM — Stock Options Channel
MGNX is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

RLYP News
AGIO News
TRVN News
OPHT News
AKBA News
VTL News
RXDX News
CBMG News
APT News
CTLT News

Consider RediNews RSS feeds to complement your web page financial content. Whether below a detailed quote page, a stock history chart, or featured on your home page, RediNews has an RSS feed to meet your needs. Integrate news by specific stock symbol, or an entire market sector. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): .

MGNX News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.